BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 26825166)

  • 1. Neutrophilic Dermatosis Limited to Lipo-Lymphedematous Skin in a Morbidly Obese Woman on Dasatinib Therapy.
    Ainechi S; Carlson JA
    Am J Dermatopathol; 2016 Feb; 38(2):e22-6. PubMed ID: 26825166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent and Fixed Neutrophilic Dermatosis Associated With Dasatinib.
    Bergman JC; Ly TY; Keating MM; Hull PR
    J Cutan Med Surg; 2018; 22(6):621-623. PubMed ID: 29754527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recurrent neutrophilic panniculitis in a patient with chronic myelogenous leukaemia treated with imatinib mesilate and dasatinib].
    de Masson A; Bouvresse S; Clérici T; Mahé E; Saïag P
    Ann Dermatol Venereol; 2011 Feb; 138(2):135-9. PubMed ID: 21333826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sweet syndrome in a patient with chronic myelogenous leukemia under dasatinib treatment.
    Matsuda T; Ueda-Hayakawa I; Kambe N; Fujita S; Okamoto H
    J Dermatol; 2019 Sep; 46(9):e317-e318. PubMed ID: 30932238
    [No Abstract]   [Full Text] [Related]  

  • 5. Ketoconazole-induced Sweet syndrome: a new association.
    Baquerizo Nole KL; Lee E; Villada G; Romanelli P
    Am J Dermatopathol; 2015 May; 37(5):419-22. PubMed ID: 25590289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophilic urticarial dermatosis: a variant of neutrophilic urticaria strongly associated with systemic disease. Report of 9 new cases and review of the literature.
    Kieffer C; Cribier B; Lipsker D
    Medicine (Baltimore); 2009 Jan; 88(1):23-31. PubMed ID: 19352297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmunity-related neutrophilic dermatosis: a newly described entity that is not exclusive of systemic lupus erythematosus.
    Saeb-Lima M; Charli-Joseph Y; Rodríguez-Acosta ED; Domínguez-Cherit J
    Am J Dermatopathol; 2013 Aug; 35(6):655-60. PubMed ID: 23518639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophilic urticarial dermatosis and Sweet-like neutrophilic dermatosis: under-recognized neutrophilic dermatoses in lupus erythematosus.
    Lee WJ; Kang HJ; Shin HJ; Won CH; Chang SE; Choi JH; Lee MW
    Lupus; 2018 Apr; 27(4):628-636. PubMed ID: 29058993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophilic dermatoses: a review of current treatment options.
    Cohen PR
    Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sweet syndrome-like neutrophilic infiltrate as initial presentation of acute myelogenous leukemia.
    Travassos AR; Soares-de-Almeida L; Kutzner H; Guerra L; Alves do Carmo J; Filipe P; Marques MS
    Am J Dermatopathol; 2014 Oct; 36(10):e167-70. PubMed ID: 23538898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophilic dermatosis after azathioprine exposure.
    Cyrus N; Stavert R; Mason AR; Ko CJ; Choi JN
    JAMA Dermatol; 2013 May; 149(5):592-7. PubMed ID: 23677084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bullous Sweet syndrome as a presentation of chronic myelogenous leukaemia.
    Abbas SW; Shah Z; Shaikh MU
    BMJ Case Rep; 2022 Dec; 15(12):. PubMed ID: 36455980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imatinib-induced sweet syndrome in a patient with chronic myeloid leukemia.
    Ayirookuzhi SJ; Ma L; Ramshesh P; Mills G
    Arch Dermatol; 2005 Mar; 141(3):368-70. PubMed ID: 15781678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sweet's syndrome without granulocytosis.
    Probert C; Ehmann WC; al-Mondhiry H; Ballard J; Helm KF
    Int J Dermatol; 1998 Feb; 37(2):108-12. PubMed ID: 9542664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sweet's syndrome after splenic irradiation for chronic myelogenous leukemia.
    Pertusi RM; Forman MD; Brown AC
    J Am Osteopath Assoc; 1996 Jun; 96(6):366-7. PubMed ID: 8690626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophilic fixed drug eruption, a histopathologic variant or an expected finding?-A report of two cases and review of the literature.
    Theroux Z; Gardner J; Ortiz E; Kosik G; Junkins-Hopkins J
    J Cutan Pathol; 2023 Oct; 50(10):884-889. PubMed ID: 37403191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dasatinib for chronic myelogenous leukemia improves skin symptoms of systemic sclerosis.
    Arai K; Yoshifuji K; Motomura Y; Sonokawa S; Suzuki S; Kumagai T
    Int J Hematol; 2019 Jun; 109(6):718-722. PubMed ID: 30788724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphedema-associated neutrophilic dermatosis: Two cases of localized Sweet syndrome on the lymphedematous lower limbs.
    Chu CH; Cheng YP; Kao HL; Liang CW; Chan JY; Yu Y
    J Dermatol; 2016 Sep; 43(9):1062-6. PubMed ID: 27099208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bortezomib-induced eruption: Sweet syndrome? Two case reports].
    Thuillier D; Lenglet A; Chaby G; Royer R; Vaida I; Viseux V; Dadban A; Billet A; Christophe O; Chatelain D; Marolleau JP; Lok C; Damaj G
    Ann Dermatol Venereol; 2009 May; 136(5):427-30. PubMed ID: 19442799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pemetrexed-induced Sweet Syndrome: First case report in the medical literature.
    Korkmaz M; Eryılmaz MK; Karaağaç M; Demirkıran A; Araz M; Artaç M
    J Oncol Pharm Pract; 2021 Jul; 27(5):1307-1310. PubMed ID: 33028131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.